Selecting biotech-derived ingredients without compromising performance
Last update on Apr 22, 2026
The cosmetics and personal care industry is clearly evolving, driven by sustainability targets, ongoing supply chain pressures, and the need for more reliable formulation performance. In this context, biotech-derived ingredients are no longer just emerging concepts, but are being used across a wide range of formulations4.
Ingredients produced via fermentation, enzymatic transformation, or cell culture are now widely available, often from multiple suppliers. This makes them a viable option for formulators working under time, cost, and performance constraints1.
From a formulation perspective, this shift is less about replacing “natural” or “synthetic” ingredients. It is more about gaining better control over consistency and performance in the final product.
In this article, we will explore how moving beyond traditional ingredient sourcing enables formulators to leverage the benefits of biotechnology, bringing greater consistency, scalability, and performance to cosmetic formulations.
What are biotech-derived ingredients?
In simple terms, biotech-derived ingredients are materials produced or enhanced through biological processes such as:
- fermentation,
- enzymatic transformation, or
- bioengineering4
What makes them particularly relevant is not just how they are produced, but the level of control they offer. Compared to more traditional raw materials, there is usually better consistency in composition and performance, which can make a real difference during formulation.

Fermentation-derived ingredients
Among the different biotech approaches, fermentation is probably the most established and widely used in cosmetics today. This is mainly because it scales well and delivers consistent results5.
A well-known example is hyaluronic acid (HA). It was historically sourced from animal tissues. It is now almost entirely produced via microbial fermentation. This has improved both purity and batch-to-batch consistency2.
In practice, formulators can select from different molecular weights to adjust hydration, penetration, and film-forming properties. This flexibility is one of the main reasons HA continues to be so widely used, as relatively small changes can noticeably impact both performance and skin feel2.
Polyglutamic acid (PGA), typically produced using Bacillus subtilis, is another example. It is often compared to HA due to its strong water-binding capacity, although it tends to give a more pronounced film-forming effect.
Biosurfactants such as sophorolipids and rhamnolipids are also becoming more common. They are generally milder and more biodegradable. However, they do not always behave exactly like conventional surfactants and may require some adjustment during formulation5,6.
Enzyme-engineered and bio-transformed ingredients
This category includes ingredients that are not fully biotech-derived but are improved through enzymatic or biological processes.
For example, enzymatically modified oils and esters. They often show better spreadability and a more refined sensory profile. These are differences that tend to become obvious during formulation work, even if they are not always highlighted in technical data sheets.
Fermented botanical extracts are another area of interest. In some cases, fermentation can improve consistency and enhance certain properties, such as antioxidant activity or bioavailability. However, the results are not always uniform and they depend heavily on the process and raw material used4.
Precision biotech and advanced actives
At the more advanced end, precision biotech encompasses engineered ingredients, including recombinant peptides and proteins. These are designed for targeted biological activity3.
These materials are increasingly used in applications such as anti-aging or skin repair. However, from a practical perspective, cost and scalability still limit their broader use.
A good example of a more established solution is bio-based squalane produced via yeast fermentation. This offers consistent quality and traceability while maintaining the expected performance as an emollient.

Increasing complexity, specificity, and cost of biotech-derived ingredients in cosmetic formulations
How to select biotech-derived ingredients?
Performance vs. sustainability
- Draelos, Z. D. (2018). Cosmetic Dermatology: Products and Procedures. Wiley.
- Fallacara, A., Baldini, E., Manfredini, S., & Vertuani, S. (2018). Hyaluronic acid in the third millennium. Polymers, 10(7), 701.
- Gorouhi, F., & Maibach, H. I. (2009). Role of topical peptides in skin care. International Journal of Cosmetic Science, 31(5), 327–345.
- Lintner, K., et al. (2020). Biotechnology in cosmetics: An overview. International Journal of Cosmetic Science.
- Marchant, R., & Banat, I. M. (2012). Microbial biosurfactants: challenges and opportunities. Biotechnology Letters, 34(9), 1597–1605.
- Mukherjee, S., Das, P., & Sen, R. (2006). Biosurfactants: production and application. Trends in Biotechnology, 24(11), 509–515.
- ISO 14040:2006. Environmental management — Life cycle assessment — Principles and framework.
- Ginkgo Bioworks. (2021, 14 de abril). Ingredient Replacement Map: Biotech shifts ingredients from Traditional inputs to Engineered performance. Grow by Ginkgo. Recuperado de growbyginkgo.com
